100 likes | 351 Views
The report provides a comprehensive discussion of NGS technologies, clinical applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for clinical genetic testing. https://www.bharatbook.com/biotechnology-market-research-reports-181764/next-generation-sequencing-emerging-clinical-global.html
E N D
Next-Generation Sequencing: Emerging Clinical Applications and Global Markets
Summary The global clinical next-generation sequencing (NGS) market was valued at $886.1 million in 2014. This market is expected to grow at a compound annual growth rate (CAGR) of 31.3%, from $997.1 million in 2015 to nearly $3.9 billion by 2020.This report provides:-An overview of the global market for next-generation sequencing and its emerging clinical applications.-Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.-Examination of the sequencing industry structure for key market segments.-Discussion covering the strategies employed by the main companies in the market.-Comprehensive company profiles of major players in the field. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
INTRODUCTIONSTUDY GOALS AND OBJECTIVESThis Report Research’s goal for this study is to provide an in-depth analysis of the clinical next-generation sequencing (NGS) industry, an emerging industry with enormous market potential. The approach of analyzing the industry is taken in terms of workflow (e.g., sequencers, sequence capture, informatics) and key indications where NGS diagnostics will have market share by 2020.This Research examines the markets for NGS diagnostics for the years 2014, 2015 and 2020.The global NGS diagnostic markets are characterized and quantified by disease indication, test complexity, test purpose and geography.Market segments that provide exceptional growth opportunities include cancer, rare genetic diseases and reproductive health. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
The report provides a comprehensive discussion of NGS technologies, clinical applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for clinical genetic testing. REASONS FOR DOING THE STUDY The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
The HGP led to significant improvements in the efficiency and costs of DNA sequencing. During this time period, the sequencing industry consolidated, resulting in one dominant company, Applied Biosystems (now Thermo Fisher Scientific). Beginning in 2005, the launch of next-generation sequencing technologies radically changed the structure of the industry and opened up exciting new market applications. The costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE This report fills a gap in the industry by focusing solely on clinical applications run on next-generation sequencing instruments. Because this industry shows great promise, information about the market will be particularly useful to companies and other institutions. The report provides a roadmap for understanding the ways in which next-generation sequencing will be used in the diagnostic business during the next five years. It is a useful guide for strategic and business planning, as well as for learning about the impact new sequencing technologies will have in clinical diagnostics. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
This market report will be useful to many companies involved in the clinical, genetic testing and sequencing industries. It will be particularly valuable for companies in such industries as life science research tools, NGS instruments, molecular diagnostics, informatics clinical laboratories, pharmaceutical, biotechnology, microfluidics, lab-on-a-chip and sample preparation. SCOPE AND FORMAT The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2014, 2015 and 2020. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
Table of Contents INTRODUCTION EXECUTIVE SUMMARY OVERVIEW TECHNOLOGIES TOP 10 CLINICAL NGS INITIATIVES CLINICAL NGS APPLICATIONS CLINICAL NGS INDUSTRY NGS DIAGNOSTICS MARKETS W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
To view the full Executive Summary and Table of Contents, please visit: Next-Generation Sequencing: Emerging Clinical Applications and Global Markets Contact Us:Bharat Book BureauCall us: +91-22-27810772 / 73Email id : info@bharatbook.comBlog : https://www.bharatbook.com/blog/ Follow Us On :